# Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting

> **NCT02095366** · PHASE4 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 194 (actual)

## Conditions studied

- Severe Traumatic Pain
- Numeric Pain Rating Scale > 5 / 10

## Interventions

- **DRUG:** Morphine
- **DRUG:** Sufentanil
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02095366
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-02
- **Primary completion:** 2016-04-10
- **Final completion:** 2016-06-30
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02095366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02095366, "Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02095366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*